|
1
|
Chen N, Yang X, Guo W, You J, Wu Q, Zhang
G, Li H, Geng D, Jin T, Fu J and Zhang Y: Association of
polymorphisms in the telomere-related gene ACYP2 with lung cancer
risk in the Chinese Han population. Oncotarget. 7:87473–87478.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang C, Liu S, Wang H, Zhang Z, Yang Q
and Gao F: LncRNA PVT1 overexpression is a poor prognostic
biomarker and regulates migration and invasion in small cell lung
cancer. Am J Transl Res. 8:5025–5034. 2016.PubMed/NCBI
|
|
3
|
Shen Y, Tian Z, Lu D, Huang J, Zhang Z, Li
X and Li J: Impact of pneumonia and lung cancer on mortality of
women with hypertension. Sci Rep. 6:202016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shahid M, Choi TG, Nguyen MN, Matondo A,
Jo YH, Yoo JY, Nguyen NN, Yun HR, Kim J, Akter S, et al: An 8-gene
signature for prediction of prognosis and chemoresponse in
non-small cell lung cancer. Oncotarget. 7:86561–86572. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xing P, Wang S, Hao X, Zhang T and Li J:
Clinical data from the real world: Efficacy of Crizotinib in
Chinese patients with advanced ALK-rearranged non-small cell lung
cancer and brain metastases. Oncotarget. 7:84666–84674. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu K, Chen HL, Gu MM and You QS: A three
gene-based risk score predicts prognosis of resected non-small-cell
lung cancer. Int J Clin Exp Pathol. 8:16081–16088. 2015.PubMed/NCBI
|
|
7
|
Yazawa T, Kaira K, Shimizu K, Shimizu A,
Mori K, Nagashima T, Ohtaki Y, Oyama T, Mogi A and Kuwano H:
Prognostic significance of β2-adrenergic receptor expression in
non-small cell lung cancer. Am J Transl Res. 8:5059–5070.
2016.PubMed/NCBI
|
|
8
|
Chiba M, Togashi Y, Tomida S, Mizuuchi H,
Nakamura Y, Banno E, Hayashi H, Terashima M, De Velasco MA, Sakai
K, et al: MEK inhibitors against MET-amplified non-small cell lung
cancer. Int J Oncol. 49:2236–2244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kotsakis A, Koinis F, Katsarou A,
Gioulbasani M, Aggouraki D, Kentepozidis N, Georgoulias V and
Vetsika EK: Prognostic value of circulating regulatory T cell
subsets in untreated non-small cell lung cancer patients. Sci Rep.
6:392472016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lingzi X, Zhihua Y, Xuelian L, Yangwu R,
Haibo Z, Yuxia Z and Baosen Z: Genetic variants in microRNAs
predict non-small cell lung cancer prognosis in Chinese female
population in a prospective cohort study. Oncotarget.
7:83101–83114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song J, Liu Z, Zhong W, Huang Y, Ma Z,
Dong D, Liang C and Tian J: Non-small cell lung cancer:
Quantitative phenotypic analysis of CT images as a potential marker
of prognosis. Sci Rep. 6:382822016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang W, Han M, Ruan B, Jin W, Lou J, Yuan
X, Chen D, Chen Y, Shin VY, Jin H and Wang X: Overexpression of
GOLPH3 is associated with poor survival in Non-small-cell lung
cancer. Am J Transl Res. 8:1756–1762. 2016.PubMed/NCBI
|
|
13
|
Li D and He S: Pemetrexed and
cyclophosphamide combination therapy for the treatment of non-small
cell lung cancer. Int J Clin Exp Pathol. 8:14693–14700.
2015.PubMed/NCBI
|
|
14
|
Xia X, Lu JJ, Zhang SS, Su CH and Luo HH:
Midkine is a serum and urinary biomarker for the detection and
prognosis of non-small cell lung cancer. Oncotarget. 7:87462–87472.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kondo M, Yamamoto T, Takahashi S and Taira
M: Comprehensive analyses of hox gene expression in Xenopus laevis
embryos and adult tissues. Dev Growth Differ. 59:526–539. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu DC, Wang SSW, Liu CJ, Wuputra K, Kato
K, Lee YL, Lin YC, Tsai MH, Ku CC, Lin WH, et al: Reprogramming
Antagonizes the Oncogenicity of HOXA13-Long Noncoding RNA HOTTIP
Axis in gastric cancer cells. Stem Cells. 35:2115–2128. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang S, Liu J, Guo S, He S, Qiu G, Lu J,
Wang J, Fan L, Zhao W and Che X: HOTTIP and HOXA13 are oncogenes
associated with gastric cancer progression. Oncol Rep.
35:3577–3585. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duan R, Han L, Wang Q, Wei J, Chen L,
Zhang J, Kang C and Wang L: HOXA13 is a potential GBM diagnostic
marker and promotes glioma invasion by activating the Wnt and TGF-β
pathways. Oncotarget. 6:27778–27793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong Y, Cai Y, Liu B, Jiao X, Li ZT, Guo
DY, Li XW, Wang YJ and Yang DK: HOXA13 is associated with
unfavorable survival and acts as a novel oncogene in prostate
carcinoma. Future Oncol. 13:1505–1516. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang SS, Wuputra K, Liu CJ, Lin YC, Chen
YT, Chai CY, Lin CS, Kuo KK, Tsai MH, Wang SW, et al: Oncogenic
function of the homeobox A13-long noncoding RNA HOTTIP-insulin
growth factor-binding protein 3 axis in human gastric cancer.
Oncotarget. 7:36049–36064. 2016.PubMed/NCBI
|
|
22
|
Chandrasekaran G, Hwang EC, Kang TW, Kwon
DD, Park K, Lee JJ and Lakshmanan VK: Computational Modeling of
complete HOXB13 protein for predicting the functional effect of
SNPs and the associated role in hereditary prostate cancer. Sci
Rep. 7:438302017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saha SS, Chowdhury RR, Mondal NR, Roy S
and Sengupta S: Expression signatures of HOX cluster genes in
cervical cancer pathogenesis: Impact of human papillomavirus type
16 oncoprotein E7. Oncotarget. 8:36591–36602. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kelly Z, Moller-Levet C, McGrath S,
Butler-Manuel S, Madhuri Kavitha T, Kierzek AM, Pandha H, Morgan R
and Michael A: The prognostic significance of specific HOX gene
expression patterns in ovarian cancer. Int J Cancer. 139:1608–1617.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sang Y, Zhou F, Wang D, Bi X, Liu X, Hao
Z, Li Q and Zhang W: Up-regulation of long non-coding HOTTIP
functions as an oncogene by regulating HOXA13 in non-small cell
lung cancer. Am J Transl Res. 8:2022–2032. 2016.PubMed/NCBI
|
|
26
|
Kang JU: Characterization of amplification
patterns and target genes on the short arm of chromosome 7 in
early-stage lung adenocarcinoma. Mol Med Rep. 8:1373–1378. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou J, Aerts J, den Hamer B, van Ijcken W,
den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens
JA, Hoogsteden HC, et al: Gene expression-based classification of
non-small cell lung carcinomas and survival prediction. PLoS One.
5:1932–6203. 2010. View Article : Google Scholar
|
|
28
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Garber ME, Troyanskaya OG, Schluens K,
Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen
GD, Perou CM, Whyte RI, et al: Diversity of gene expression in
adenocarcinoma of the lung. Proc Natl Acad Sci USA. 98:13784–13789.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen G, Kronenberger P, Umelo IA, Teugels
E and De Grève J: Quantification of epidermal growth factor
receptor T790M mutant transcripts in lung cancer cells by real-time
reverse transcriptase-quantitative polymerase chain reaction. Anal
Biochem. 398:266–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo B, Che T, Shi B, Guo L, Zhang Z, Li L,
Cai C and Chen Y: Interaction network analysis of differentially
expressed genes and screening of cancer marker in the urine of
patients with invasive bladder cancer. Int J Clin Exp Med.
8:3619–3628. 2015.PubMed/NCBI
|
|
33
|
Cheng Y, Jutooru I, Chadalapaka G, Corton
JC and Safe S: The long non-coding RNA HOTTIP enhances pancreatic
cancer cell proliferation, survival and migration. Oncotarget.
6:10840–10852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Glas AS, Lijmer JG, Prins MH, Bonsel GJ
and Bossuyt PM: The diagnostic odds ratio: A single indicator of
test performance. J Clin Epidemiol. 56:1129–1135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Walter SD: Properties of the summary
receiver operating characteristic (SROC) curve for diagnostic test
data. Stat Med. 21:1237–1256. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng N, Salker MS, Zhang S, Singh Y, Shi
B, Stournaras C and Lang F: 1α,25(OH)2D3 induces actin
depolymerization in endometrial carcinoma cells by targeting RAC1
and PAK1. Cell Physiol Biochem. 40:1455–1464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Raja R, Sahasrabuddhe NA, Radhakrishnan A,
Syed N, Solanki HS, Puttamallesh VN, Balaji SA, Nanjappa V, Datta
KK, Babu N, et al: Chronic exposure to cigarette smoke leads to
activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small
cell lung cancer cells. Oncotarget. 7:61229–61245. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang M, Dong Q and Wang Y: Rab23 is
overexpressed in human astrocytoma and promotes cell migration and
invasion through regulation of Rac1. Tumour Biol. 37:11049–11055.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Z, Guo C, Liu X, Zhou C, Zhu F, Wang X,
Wang Q, Shi Y, Wang J, Zhao W and Zhang L: TIPE2 suppresses
angiogenesis and non-small cell lung cancer (NSCLC) invasiveness
via inhibiting Rac1 activation and VEGF expression. Oncotarget.
7:62224–62239. 2016.PubMed/NCBI
|
|
40
|
Chen L, DeWispelaere A, Dastvan F, Osborne
WR, Blechner C, Windhorst S and Daum G: Smooth Muscle-Alpha actin
inhibits vascular smooth muscle cell proliferation and migration by
inhibiting Rac1 activity. PLoS One. 11:e01557262016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cho CY, Lee KT, Chen WC, Wang CY, Chang
YS, Huang HL, Hsu HP, Yen MC, Lai MZ and Lai MD: MST3 promotes
proliferation and tumorigenicity through the VAV2/Rac1 signal axis
in breast cancer. Oncotarget. 7:14586–14604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zou T, Mao X, Yin J, Li X, Chen J, Zhu T,
Li Q, Zhou H and Liu Z: Emerging roles of RAC1 in treating lung
cancer patients. Clin Genet. 91:520–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
